You searched for "MET"
Movember launches world’s largest cancer real world evidence network
Movember has launched the world’s largest prostate cancer and testicular clinical and research network, aimed at improving the overall survival and quality of life for those living with diseases that affect over 1.4 million men worldwide every year. The leading...‘Man van’ launched to speed up cancer diagnosis and improve healthcare access
The ‘Man Van’, an innovative new outreach programme, was launched in March this year to provide free health checks for men and boost early diagnosis of prostate and other urological cancers. The mobile health clinic will visit workplaces and churches...MUC (Midlands Urology Club) Annual Meeting
The Midlands Urology Club (MUC) Meeting is back in Walsall this year. An eminent panel of Urologists will be talking to us on various aspects of clinical practice. Talks include updates from Mr A Birring & Mr KJ Ho on Genito-Urethral Reconstruction Services and Management of Penile Cancer in West Midlands, respectively. Mr C Luscombe will be leading a session on Implementation of the GIRFT A&G in the region. The event is fully subscribed now with LEDS, NTN’s, FYs & CTS as well as senior clinicians registered for the meeting. This is an opportunity to learn, get up-to-date on local practice and meet fellow colleagues in the area. Audits from various trusts in the region will be presented in the afternoon. Lunch and refreshments have kindly been provided by our sponsors.Peyronie’s disease: a review and update
Peyronie’s disease (PD) describes an acquired disease of the penis, which is characterised by a number of signs and symptoms. These include penile pain, curvature, palpable plaques, wasting or narrowing of the penile shaft, a hinge deformity and potentially catastrophic...Prostate cancer management 2 – metastatic disease
A 72-year-old gentleman is referred to you in the two-week wait clinic with a prostate specific antigen (PSA) of 22ug/L. He is otherwise fit and well and does not take any regular medication. His multi-parametric magnetic resonance imaging (mpMRI) shows...Improving on the Rotterdam Prostate Cancer Risk Calculator
Following the PROMIS trial [1], many cancer centres in the UK are now offering pre-biopsy multiparametric MRI (mpMRI) for men suitable for radical treatment. The European Association of Urology for Prostate Cancer (PCa) guidelines recommend individual risk stratification before the...Using cryopreserved prepubertal testis tissues – are we getting warmer?
The rising incidence of childhood cancer coupled with increasing survivorship means there is a growing population of childhood cancer survivors with unmet health needs. In the UK around 1 in 500 children and young people are survivors of childhood cancer....The assessment and medical treatment of LUTS secondary to BPH
The term benign prostatic hyperplasia (BPH) describes prostate enlargement due to non-cancerous processes. Several aetiological mechanisms are involved, including hormonal and vascular alterations; abnormal regulation of apoptosis; and prostatic inflammation, which may stimulate cellular proliferation. With ageing, prostate enlargement can...
Performance of non-invasive tests in diagnosing BOO in men with LUTS
A large proportion of urology involves the treatment of bladder outflow obstruction (BOO) in men. Yet BOO in men is very difficult to accurately quantify with the only regular non-invasive test being uroflowmetry. Pressure flow urodynamics may be considered the...
Do adult men with untreated ventral penile curvature have adverse outcomes?
The history of ventral penile curvature if untreated in childhood is not known. The authors tried to assess this by performing an online survey of adults who had untreated ventral penile curvature using a Facebook advertised survey. Their outcome measures...
